Literature DB >> 1923440

Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations.

T F Meiller1, M J Kutcher, C D Overholser, C Niehaus, L G DePaola, M A Siegel.   

Abstract

Recurrent aphthous ulceration (RAU) remains a clinical problem for many patients. Efforts in prevention and/or treatment with prescription and nonprescription formulations have to date resulted in minimal success at best. A 6-month double-blind clinical study of 96 adults compared a commercially available antimicrobial mouthrinse (Listerine Antiseptic [LA], Warner-Lambert Co., Morris Plains, N.J.) and a hydroalcoholic control to evaluate the effects of vigorous twice-daily rinsing on the incidence, duration, and severity of RAU in persons prone to this disorder. LA rinse and the hydroalcoholic rinse resulted in a statistically significant reduction in the incidence of RAU occurrences from baseline. The duration of lesions and the severity of pain in subjects with ulcers during the treatment period were also significantly reduced in the LA rinse group of patients when compared with baseline. The hydroalcoholic rinse did not show a significant effect versus baseline for either severity or duration of the lesions. Rinsing therefore can be of clinical value in reducing the occurrence of RAU in susceptible patients, and LA rinse can be of significant additional value in decreasing the duration and severity of RAU.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923440     DOI: 10.1016/0030-4220(91)90553-o

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  10 in total

Review 1.  Aphthous ulcers (recurrent).

Authors:  Konrad Staines; Mark Greenwood
Journal:  BMJ Clin Evid       Date:  2015-02-26

Review 2.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

Review 3.  Aphthous ulcers (recurrent).

Authors:  Stephen R Porter; Crispian Scully Cbe
Journal:  BMJ Clin Evid       Date:  2007-06-01

Review 4.  Differential diagnosis and management of Behçet syndrome.

Authors:  Nicola L Ambrose; Dorian O Haskard
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

5.  Amlexanox for the treatment of recurrent aphthous ulcers.

Authors:  Juliette Bell
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

Authors:  William B Armstrong; Thomas H Taylor; Ann R Kennedy; Raymond J Melrose; Diana V Messadi; Mai Gu; Anh D Le; Marjorie Perloff; Francisco Civantos; William Jarrard Goodwin; Lori J Wirth; Alexander Ross Kerr; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2013-05

7.  New Evidence-Based Treatment Approach in Behçet's Disease.

Authors:  Erkan Alpsoy
Journal:  Patholog Res Int       Date:  2011-10-05

8.  Relative Efficacy of Quercetin Compared with Benzydamine Hydrochloride in Minor Aphthae: A Prospective, Parallel, Double Blind, Active Control, Preliminary Study.

Authors:  Maitreyi Pandya; Anupama N Kalappanavar; Rajeshwari G Annigeri; Dhanya S Rao
Journal:  Int J Dent       Date:  2017-11-13

Review 9.  Experimental Therapeutic Solutions for Behcet's Disease.

Authors:  Burçin Cansu Bozca; Erkan Alpsoy
Journal:  J Exp Pharmacol       Date:  2021-02-12

Review 10.  Evolution of Drug Delivery Systems for Recurrent Aphthous Stomatitis.

Authors:  Ine Suharyani; Ahmed Fouad Abdelwahab Mohammed; Muchtaridi Muchtaridi; Nasrul Wathoni; Marline Abdassah
Journal:  Drug Des Devel Ther       Date:  2021-09-27       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.